Adverum Biotechnologies Inc (ADVM)
4.85
+0.11
(+2.32%)
USD |
NASDAQ |
Dec 26, 11:43
Adverum Biotechnologies Free Cash Flow: -86.06M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| EyePoint Pharmaceuticals Inc | -118.04M |
| Cassava Sciences Inc | -78.07M |
| Regenxbio Inc | -184.74M |
| Editas Medicine Inc | -191.36M |
| Apellis Pharmaceuticals Inc | -205.58M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -21.12M |
| Cash from Investing (Quarterly) | -13.35M |
| Free Cash Flow Per Share (Quarterly) | -1.022 |
| Free Cash Flow to Equity (Quarterly) | -21.34M |
| Free Cash Flow to Firm (Quarterly) | -21.34M |
| Free Cash Flow Yield | -103.9% |